Artificial Intelligence in Drug Discovery Market Research Report, By Product Type (Software, Services), Molecule Type (Large Molecule, Small Molecule), Technology (Machine Learning, Deep Learning and others), Indication (Immune-Oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases and others), Application (Target Identification, Candidate Screening, De novo Drug Designing, Drug Optimization and Repurposing and Preclinical Testing) - Forecast till 2027

Table of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global AI in Drug Discovery Market, by Product Type

1.1.2. Global AI in Drug Discovery Market, by Molecule Type

1.1.3. Global AI in Drug Discovery Market, by Technology

1.1.4. Global AI in Drug Discovery Market, by Indication

1.1.5. Global AI in Drug Discovery Market, by Application

1.1.6. Global AI in Drug Discovery Market, by End User

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.2.1. Secondary Research

3.2.2. Primary Research

3.2.2.1. Breakdown of Primary Respondents

3.2.3. Forecasting Techniques

3.3. Research Methodology for Market Size Estimation

3.3.1. Bottom-Up Approach

3.3.2. Top-Down Approach

3.4. Data Triangulation

3.5. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

5.2.1. R&D and Designing

5.2.2. Manufacturing

5.2.3. Distribution & Sales

5.2.4. Post Sales Services

6. GLOBAL AI IN DRUG DISCOVERY MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Software

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

6.3. Services

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7. GLOBAL AI IN DRUG DISCOVERY MARKET, BY MOLECULE TYPE

7.1. Overview

7.2. Large Molecule

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

7.3. Small Molecule

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8. GLOBAL AI IN DRUG DISCOVERY MARKET, BY TECHNOLOGY

8.1. Overview

8.2. Machine Learning

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.3. Deep Learning

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

8.4 Others

9. GLOBAL AI IN DRUG DISCOVERY MARKET, BY INDICATION

9.1. Overview

9.2. Immuno-Oncology

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.3. Neurodegenerative Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.4. Cardiovascular Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.5. Metabolic Diseases

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

9.6. Others

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10. GLOBAL AI IN DRUG DISCOVERY MARKET, BY APPLICATION

10.1. Overview

10.2. Target Identification

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10.3. Candidate Screening

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10.4. De novo Drug Designing

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10.5. Drug Optimization and Repurposing

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

10.6. Preclinical Testing

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

11. GLOBAL AI IN DRUG DISCOVERY MARKET, BY END USER

11.1. Overview

11.2. Pharmaceutical & Biotechnology Companies

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

11.3. Contract Research Organizations

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

11.4. Research Centers and Academic & Government Institutes

Market Estimates & Forecast, by Region, 2020–2027

Market Estimates & Forecast, by Country, 2020–2027

12. GLOBAL AI IN DRUG DISCOVERY MARKET, BY REGION

12.1. Overview

12.2. Americas

12.2.1. North America

12.2.1.1. US

12.2.1.2. Canada

12.2.2. Latin America

12.3. Europe

12.3.1. Western Europe

12.3.1.1. Germany

12.3.1.2. France

12.3.1.3. UK

12.3.1.4. Italy

12.3.1.5. Spain

12.3.1.6. Rest of Western Europe

12.3.2. Eastern Europe

12.4. Asia-Pacific

12.4.1. Japan

12.4.2. China

12.4.3. India

12.4.4. Australia

12.4.5. South Korea

12.4.6. Rest of Asia-Pacific

12.5. Middle East & Africa

12.5.1. Middle East

12.5.2. Africa

13. COMPANY LANDSCAPE

13.1. Overview

13.2. Competitor Dashboard

13.2.1. Company Share Analysis

13.2.2. Major Growth Strategy in the global AI in Drug Discovery Market

13.3. Competitive Benchmarking

13.3.1. Leading Players in terms of Number of Developments in the Global AI in Drug Discovery Market

13.3.2. Key Developments & Growth Strategies

13.3.3. Major Players Financial Matrix & Market Ratio

14. COMPANY PROFILE

14.1. Microsoft Corporation

14.1.1. Company Overview

14.1.2. Products/Services Offered

14.1.3. Financial Overview

14.1.4. Key Developments

14.1.5. SWOT Analysis

14.1.6. Key Strategies

14.2. NVIDIA Corporation

14.3. IBM Corporation

14.4. Google (A Subsidiary of Alphabet Inc.)

14.5. Atomwise, Inc.

14.6. Deep Genomics

14.7. Cloud Pharmaceuticals, Inc.

14.8. Insilico Medicine

14.9. Benevolentai

14.10. Exscientia

14.11. Cyclica

14.12. Bioage

14.13. Numerate

14.14. Numedii, Inc.

14.15. Envisagenics

14.16. Twoxar, Incorporated

14.17. Owkin, Inc.

14.18. Xtalpi, Inc.

14.19. Verge Genomics

14.20. Berg LLC

14.21. Others

15. APPENDIX

15.1. References

15.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

 In section 14, the top ten companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.

 Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources.